Explainable Fusion Model for Predicting Postoperative Early Recurrence in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI Habitat Imaging.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
370 patients with surgically confirmed early-stage HCC who underwent gadoxetic acid-enhanced MRI.
I · Intervention 중재 / 시술
gadoxetic acid-enhanced MRI
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The HabRad_FB, an explainable fusion model, aids clinicians in accurately and non-invasively predicting the early recurrence of HCC preoperatively. This model might provide great potential in prognostic prediction and clinical management.
[RATIONALE AND OBJECTIVES] To develop an explainable fusion model that combines clinical, radiomic, and habitat features to predict postoperative early recurrence in hepatocellular carcinoma (HCC).
- 표본수 (n) 296
APA
Qin Y, Zhang LG, et al. (2025). Explainable Fusion Model for Predicting Postoperative Early Recurrence in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI Habitat Imaging.. Academic radiology, 32(9), 5162-5172. https://doi.org/10.1016/j.acra.2025.04.018
MLA
Qin Y, et al.. "Explainable Fusion Model for Predicting Postoperative Early Recurrence in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI Habitat Imaging.." Academic radiology, vol. 32, no. 9, 2025, pp. 5162-5172.
PMID
40379586 ↗
Abstract 한글 요약
[RATIONALE AND OBJECTIVES] To develop an explainable fusion model that combines clinical, radiomic, and habitat features to predict postoperative early recurrence in hepatocellular carcinoma (HCC).
[METHODS] The bicentric retrospective study included 370 patients with surgically confirmed early-stage HCC who underwent gadoxetic acid-enhanced MRI. The patients were stratified into a training cohort (n=296) and an external validation cohort (n=74). From the hepatobiliary phase images, habitat and radiomics features were extracted across the entire tumor and used to construct radiomics and habitat models. Additionally, a clinical model was established utilizing relevant clinical features. Subsequently, all previously mentioned features were merged to construct the fusion model (HabRad_FB). Diagnostic performance of these models was assessed and compared using the area under the receiver operating characteristic curve (AUC), net reclassification index (NRI), and integrated discrimination improvement (IDI). The fusion model was then interpreted using SHapley Additive exPlanations (SHAP) analysis.
[RESULTS] Tumor recurrence was observed in 73 out of 370 patients (19.7%; 55.2±11.3 years; male=333). Among all study cohorts, the HabRad_FB model showed the highest AUC (0.820-0.959), outperforming the clinical (0.517-0.729), radiomics (0.707-0.815), and habitat (0.729-0.861) models. The HabRad_FB model also demonstrated significant improvement in IDI in the training cohort and NRI in the validation cohort. SHAP force plots provided valuable insights into the interpretation of HabRad_FB model's predictions for early recurrence.
[CONCLUSION] The HabRad_FB, an explainable fusion model, aids clinicians in accurately and non-invasively predicting the early recurrence of HCC preoperatively. This model might provide great potential in prognostic prediction and clinical management.
[METHODS] The bicentric retrospective study included 370 patients with surgically confirmed early-stage HCC who underwent gadoxetic acid-enhanced MRI. The patients were stratified into a training cohort (n=296) and an external validation cohort (n=74). From the hepatobiliary phase images, habitat and radiomics features were extracted across the entire tumor and used to construct radiomics and habitat models. Additionally, a clinical model was established utilizing relevant clinical features. Subsequently, all previously mentioned features were merged to construct the fusion model (HabRad_FB). Diagnostic performance of these models was assessed and compared using the area under the receiver operating characteristic curve (AUC), net reclassification index (NRI), and integrated discrimination improvement (IDI). The fusion model was then interpreted using SHapley Additive exPlanations (SHAP) analysis.
[RESULTS] Tumor recurrence was observed in 73 out of 370 patients (19.7%; 55.2±11.3 years; male=333). Among all study cohorts, the HabRad_FB model showed the highest AUC (0.820-0.959), outperforming the clinical (0.517-0.729), radiomics (0.707-0.815), and habitat (0.729-0.861) models. The HabRad_FB model also demonstrated significant improvement in IDI in the training cohort and NRI in the validation cohort. SHAP force plots provided valuable insights into the interpretation of HabRad_FB model's predictions for early recurrence.
[CONCLUSION] The HabRad_FB, an explainable fusion model, aids clinicians in accurately and non-invasively predicting the early recurrence of HCC preoperatively. This model might provide great potential in prognostic prediction and clinical management.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Heterogeneous nuclear ribonucleoprotein K in cancer biology and its therapeutic applications (Review).
- Distinct signatures in the human gut and oral microbiomes of gastric cancer.
- Clinical Characteristics and Prognosis of Thromboembolism in Elderly Patients With Stage IV Lung Cancer.
- Dual-lock gated DNAzyme-CRISPR cascade for amplification-free ultrasensitive profiling of FTO demethylase activity.
- Correspondence to editorial on "CD36 Promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma".
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.